Past, present and future of newborn screening in Chile

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Cornejo, V ^a   Raimann, E ^a   Cabello, J F ^a,b   Valiente, A ^a   Becerra, C ^c   Opazo, M ^d   Colombo, M ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CARLOS VAN BUREN   (Chile)

^c Ministerio de Salud de Chile   (Chile)

^d Hospital Regional de Concepcion Dr Guillermo Grant Benavente   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PHENYLALANINE; THYROID HORMONE;

ARTICLE; BLOOD; CHILE; CONGENITAL HYPOTHYROIDISM; DRIED BLOOD SPOT TESTING; FORECASTING; GENETIC PREDISPOSITION; GENETICS; HISTORY; HUMAN; INCIDENCE; NEWBORN; NEWBORN SCREENING; PHENOTYPE; PHENYLKETONURIA; PREDICTIVE VALUE; PROGNOSIS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; TIME; PHENYLKETONURIAS; TRENDS;

BIOLOGICAL MARKERS; CHILE; CONGENITAL HYPOTHYROIDISM; DRIED BLOOD SPOT TESTING; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; INFANT, NEWBORN; NEONATAL SCREENING; PHENOTYPE; PHENYLALANINE; PHENYLKETONURIAS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; THYROID HORMONES; TIME FACTORS;

EID: 84897925717     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9165-8     Document Type: Article

References (23)

1. American Academy of Pediatrics, Committee on Genetics (1992) Issues in newborn screening. Pediatrics 89:345-349
2. American Academy of Pediatrics Newborn Screening Authoring Committee (2008) Newborn screening expands: recommendations for pediatricians and medical homes implications for the system. Pediatrics 121:192-217
3. Bodamer OA, Hoffmann GF, Lindner M (2007) Expanded newborn screening in Europe 2007. J Inherit Metab Dis 30:439-444
4. Borrajo G (2007) Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis 30:466-481
5. Centers for Disease Control and Prevention (CDC) (2008) Impact of expanded newborn screening-United States, 2006. Morb Mortal Wkly Rep 57:1012-1015
6. Colombo M, Troncoso L, Raimann E, Perales CG, Barros T, Cornejo V (1988) Diagnóstico de Fenilquetonuria en Chile. Rev Chil Pediatr 59:235-239
7. Cornejo V, Colombo M (1986) Diagnóstico precoz de fenilquetonuria y prevención de retardo mental. In: Cornejo V, Colombo M (eds) Tesis para optar al grado de Magister en Nutrición Humana INTA. Universidad de Chile, Santiago, Chile, pp 1-67
8. Cornejo V, Raimann E, Moraga M, Colombo M (1990) Programa de rastreo neonatal de fenilquetonuria. Rev Chil Pediatr 61:309-312
9. Cornejo V, Colombo M, Durán G et al. (2002) Diagnosis and follow up of 23 children with organic acidurias. Rev Med Chile 130:259-266
10. Cornejo V, Raimann E, Colombo M (2003) Implementación y desarrollo de los programas de detección neonatal., In Colombo M, Cornejo, E., Raimann, E (eds). Errores innatos en el metabolismo del niño, Universitaria, 375-384.
11. Cornejo V, et al. (2007) Normas para el óptimo desarrollo de programas de búsqueda masiva de Fenilquetonuria (PKU), e Hipotiroidismo Congénito (HC) y otros errores congénitos del metabolismo. Editorial Ministerio de Salud, División de Prevención y Control de Enfermedades, República de Chile. Norma general técnica no 93, 1-59.
12. Cuello X, Pérez P, Vivanco X, Lobo G, Bruggendiek B, Pérez A (2004) Evaluación de 7 años de programa nacional de detección precoz de hipotiroidismo congénito en Chile. Bol Hosp San Juan de Dios 51:221-230
13. Dietzen DJ, Rinaldo P, Whitley RJ et al. (2009) National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary. Clin Chem 55:1615-1626
14. Frazier DM, Millington DS, McCandless SE et al. (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76-85
15. la Marca G, Malvagia S, Pasquini E et al. (2008) The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun Mass Spectrom 22:812-818
16. de Salud M, de Chile G (2005) Documentos, Ley 19.966: régimen general de garantías de salud. Rev Chil Obstet Ginecol 70:119-129
17. Schulze A, Linder M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann G (2003) Expanded newborn screening for inborn errors of metabolism by electrospary ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399-1406
18. Therrell BL, Adams J (2007) Newborn screening in North America. J Inherit Metab Dis 30:447-465
19. Therrell BL, Hannon WH (2006) National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev 12:236-245
20. Wilcken B (2007) Recent advances in newborn screening. J Inherit Metab Dis 30:129-133
21. Wilcken B, Webster D (1991) Neonatal screening in the nineties. In: Wilcken B (ed) International Neonatal Screening Symposium. Excepta Médica, Sydney Australia, p 372
22. Wilcken B, Haas M, Joy P et al. (2009) Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics 124:241-248
23. Wilcken B (2008) The consequences of extended newborn screening programmes: do we know who needs treatment? J Inherit Metab Dis 31:173-177